Correlation Between KB Financial and Akari Therapeutics

Can any of the company-specific risk be diversified away by investing in both KB Financial and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining KB Financial and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between KB Financial Group and Akari Therapeutics PLC, you can compare the effects of market volatilities on KB Financial and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in KB Financial with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of KB Financial and Akari Therapeutics.

Diversification Opportunities for KB Financial and Akari Therapeutics

0.37

Correlation Coefficient

KB Financial  Akari Therapeutics

Weak diversification

The 3 months correlation between KB Financial and Akari is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding KB Financial Group and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and KB Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on KB Financial Group are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of KB Financial i.e., KB Financial and Akari Therapeutics go up and down completely randomly.

Pair Corralation between KB Financial and Akari Therapeutics

Allowing for the 90-day total investment horizon KB Financial Group is expected to under-perform the Akari Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, KB Financial Group is 3.41 times less risky than Akari Therapeutics. The stock trades about -0.17 of its potential returns per unit of risk. The Akari Therapeutics PLC is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  112.00  in Akari Therapeutics PLC on November 27, 2024 and sell it today you would lose (21.00) from holding Akari Therapeutics PLC or give up 18.75% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

KB Financial Group  vs.  Akari Therapeutics PLC

KB Financial Group

Risk-Adjusted Performance

Very Weak

Over the last 90 days KB Financial Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's fundamental drivers remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Akari Therapeutics PLC

Risk-Adjusted Performance

Very Weak

Over the last 90 days Akari Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with KB Financial and Akari Therapeutics

The main advantage of trading using opposite KB Financial and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if KB Financial position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.

The idea behind KB Financial Group and Akari Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.